Amy E. Whitten

Neurocutaneous Disorders in Pregnancy.

Journal: Obstetrical & gynecological survey

Published: November 17, 2023

Metabolomic prediction of severe maternal and newborn complications in preeclampsia.

Journal: Metabolomics : Official journal of the Metabolomic Society

Published: September 07, 2023

Urine metabolomic biomarkers for prediction of isolated fetal congenital heart defect.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: May 04, 2021

Obstetrical correlates and perinatal consequences of neonatal hypoglycemia in term infants.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: July 19, 2016

The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: August 26, 2015

Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.

Journal: Journal of perinatal medicine

Published: April 15, 2013

Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.

Journal: American journal of obstetrics and gynecology

Published: November 21, 2012

Neurocutaneous Disorders in Pregnancy.

Neurocutaneous Disorders in Pregnancy.

Metabolomic prediction of severe maternal and newborn complications in preeclampsia.

Metabolomic prediction of severe maternal and newborn complications in preeclampsia.

Urine metabolomic biomarkers for prediction of isolated fetal congenital heart defect.

Urine metabolomic biomarkers for prediction of isolated fetal congenital heart defect.

Obstetrical correlates and perinatal consequences of neonatal hypoglycemia in term infants.

Obstetrical correlates and perinatal consequences of neonatal hypoglycemia in term infants.

The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Vasa previa: clinical presentations, outcomes, and implications for management.

Vasa previa: clinical presentations, outcomes, and implications for management.

Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?

Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?

Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.

Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.

Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.

Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.